Collegium Pharmaceutical, Inc (COLL): Operating Income
$179.64M
Year ended 2025-12-31
$157.44M
Trailing 12 months to 2026-06-30
+75.3%
3-year compound annual growth
+26.1%
5-year compound annual growth
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $179.64M | +5.7% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $169.90M | +1.8% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $166.96M | +401.1% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $33.32M | +89.0% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $17.63M | -68.7% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $56.23M | n/m | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | -$23.75M | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | -$20.68M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$75.45M | n/m | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | -$94.08M | n/m | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | -$26.91M | n/m | 2018-03-07, From 2015-01-01 |
| 2014-12-31 | -$17.66M | n/m | 2017-03-10, From 2014-01-01 |
| 2013-12-31 | -$16.04M | n/a | 2016-03-18, From 2013-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $179.64M | +5.7% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $44.80M | -67.3% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $100.10M | n/m |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $98.35M | n/m |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $19.19M | n/m |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $140.40M | -31.7% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | -$62.28M | n/m |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $208.47M | +9.2% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $111.09M | n/m |
Compare COLL, CORT, EBS, ARWR side by side · Screen every company in Pharmaceutical Preparations ↗